These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Whole body application of a potent topical corticosteroid for bullous pemphigoid. Terra JB; Potze WJ; Jonkman MF J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):712-8. PubMed ID: 23551654 [TBL] [Abstract][Full Text] [Related]
5. A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. Joly P; Roujeau JC; Benichou J; Delaporte E; D'Incan M; Dreno B; Bedane C; Sparsa A; Gorin I; Picard C; Tancrede-Bohin E; Sassolas B; Lok C; Guillaume JC; Doutre MS; Richard MA; Caux F; Prost C; Plantin P; Chosidow O; Pauwels C; Maillard H; Saiag P; Descamps V; Chevrant-Breton J; Dereure O; Hellot MF; Esteve E; Bernard P J Invest Dermatol; 2009 Jul; 129(7):1681-7. PubMed ID: 19177141 [TBL] [Abstract][Full Text] [Related]
6. The role of topical corticosteroids in bullous pemphigoid in the elderly. Joly P; Fontaine J; Roujeau JC Drugs Aging; 2005; 22(7):571-6. PubMed ID: 16038572 [TBL] [Abstract][Full Text] [Related]
8. [Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid]. Zimmermann R; Faure M; Claudy A Ann Dermatol Venereol; 1999 Jan; 126(1):13-6. PubMed ID: 10095883 [TBL] [Abstract][Full Text] [Related]
10. [Bullous pemphigoid: a review]. Bernard P; Charneux J Ann Dermatol Venereol; 2011 Mar; 138(3):173-81. PubMed ID: 21397147 [TBL] [Abstract][Full Text] [Related]
11. Treatment of bullous pemphigoid with topical clobetasol propionate. Westerhof W J Am Acad Dermatol; 1989 Mar; 20(3):458-61. PubMed ID: 2645323 [TBL] [Abstract][Full Text] [Related]
12. Topical class I corticosteroids in 10 patients with bullous pemphigoid: correlation of the outcome with the severity degree of the disease and review of the literature. Stockman A; Beele H; Vanderhaeghen Y; Naeyaert JM J Eur Acad Dermatol Venereol; 2004 Mar; 18(2):164-8. PubMed ID: 15009295 [TBL] [Abstract][Full Text] [Related]
13. Bullous pemphigoid treated by topical corticosteroids. Paquet P; Richelle M; Lapiere CM Acta Derm Venereol; 1991; 71(6):534-5. PubMed ID: 1685838 [TBL] [Abstract][Full Text] [Related]
14. [Interpretation of 2021 French Guidelines for the Therapeutic Management of Bullous Pemphigoid]. Wang SH; Zuo YG Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Oct; 44(5):828-836. PubMed ID: 36325781 [TBL] [Abstract][Full Text] [Related]
15. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Walters JA; Tan DJ; White CJ; Wood-Baker R Cochrane Database Syst Rev; 2018 Mar; 3(3):CD006897. PubMed ID: 29553157 [TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
18. Correlation of autoantibodies against BP180/BP230 in response to topical corticosteroids in patients with bullous pemphigoid. Schneiderbauer R; Martinache S; Engstner M; Enk AH; Hadaschik EN Dermatol Ther; 2016 Nov; 29(6):419-423. PubMed ID: 27550573 [TBL] [Abstract][Full Text] [Related]
19. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Walters JA; Tan DJ; White CJ; Gibson PG; Wood-Baker R; Walters EH Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD001288. PubMed ID: 25178099 [TBL] [Abstract][Full Text] [Related]